Evidence map›Paper›PMID 32249819›Full record

ArticleCell death and differentiation2020

Correction: The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy.

Bo Yang, Bin Zhang, Zhifei Cao, Xingdong Xu, Zihe Huo, Pan Zhang, Shufen Xiang, Zhe Zhao, Chunping Lv, Mei Meng and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death and differentiation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Bo Yang *Department of General Surgery, The Third Affiliated Hospital of Soochow University; The First People's Hospital of Changzhou, Changzhou, 213003, P.R. China.
Bin Zhang *Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Zhifei Cao *Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China. hunancao@163.com.
Xingdong XuDepartment of General Surgery, The People's Hospital of China, Three Gorges University; The First People's Hospital of Yichang, Yichang, 443000, P.R. China.
Zihe HuoCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Pan ZhangCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Shufen XiangCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Zhe ZhaoCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Chunping LvCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Mei MengCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Gaochuan ZhangDepartment of Bioinformatics, College of Basic Medical Science, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Liang DongDepartment of Pathology, College of Basic Medical Science, Soochow University, Suzhou, Jiangsu, 215123, P.R. China.
Shucheng ShiDepartment of General Surgery, The Third Affiliated Hospital of Soochow University; The First People's Hospital of Changzhou, Changzhou, 213003, P.R. China.
Lan YangDepartment of General Surgery, The Third Affiliated Hospital of Soochow University; The First People's Hospital of Changzhou, Changzhou, 213003, P.R. China.
Quansheng ZhouCyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University; State Key Laboratory of Radiation Medicine; Key Laboratory of Thrombosis and Hemostasis, Ministry of Health; 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, 215123, P.R. China. zhouqs@suda.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32249819
PMCPMC7429816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.